Vanguard Group’s CME Group CME Stock Holding History

Vanguard Group’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$9.7B	Buy	35,176,376 +532,549	+2%	+$147M	0.16%	112
2025 Q1	$9.19B	Buy	34,643,827 +400,737	+1%	+$106M	0.17%	108
2024 Q4	$7.95B	Buy	34,243,090 +326,623	+1%	+$75.9M	0.14%	114
2024 Q3	$7.48B	Buy	33,916,467 +347,333	+1%	+$76.6M	0.13%	129
2024 Q2	$6.6B	Buy	33,569,134 +165,762	+0.5%	+$32.6M	0.13%	133
2024 Q1	$7.19B	Sell	33,403,372 -47,822	-0.1%	-$10.3M	0.14%	124
2023 Q4	$7.04B	Buy	33,451,194 +215,044	+0.6%	+$45.3M	0.15%	110
2023 Q3	$6.65B	Sell	33,236,150 -73,442	-0.2%	-$14.7M	0.16%	106
2023 Q2	$6.17B	Buy	33,309,592 +24,748	+0.1%	+$4.59M	0.15%	119
2023 Q1	$6.37B	Buy	33,284,844 +145,666	+0.4%	+$27.9M	0.16%	107
2022 Q4	$5.57B	Buy	33,139,178 +371,668	+1%	+$62.5M	0.15%	122
2022 Q3	$5.8B	Buy	32,767,510 +429,912	+1%	+$76.2M	0.17%	102
2022 Q2	$6.62B	Buy	32,337,598 +489,748	+2%	+$100M	0.19%	89
2022 Q1	$7.58B	Buy	31,847,850 +490,885	+2%	+$117M	0.18%	93
2021 Q4	$7.16B	Buy	31,356,965 +254,162	+0.8%	+$58.1M	0.16%	104
2021 Q3	$6.01B	Buy	31,102,803 +219,691	+0.7%	+$42.5M	0.15%	109
2021 Q2	$6.57B	Buy	30,883,112 +275,279	+0.9%	+$58.5M	0.16%	101
2021 Q1	$6.25B	Buy	30,607,833 +2,376,218	+8%	+$485M	0.17%	98
2020 Q4	$5.14B	Sell	28,231,615 -370,502	-1%	-$67.4M	0.15%	116
2020 Q3	$4.79B	Sell	28,602,117 -514,223	-2%	-$86M	0.16%	111
2020 Q2	$4.73B	Sell	29,116,340 -252,801	-0.9%	-$41.1M	0.17%	105
2020 Q1	$5.08B	Buy	29,369,141 +747,528	+3%	+$129M	0.22%	87
2019 Q4	$5.74B	Buy	28,621,613 +383,480	+1%	+$77M	0.2%	92
2019 Q3	$5.97B	Buy	28,238,133 +245,676	+0.9%	+$51.9M	0.22%	82
2019 Q2	$5.43B	Buy	27,992,457 +328,318	+1%	+$63.7M	0.2%	86
2019 Q1	$4.55B	Buy	27,664,139 +392,627	+1%	+$64.6M	0.18%	98
2018 Q4	$5.13B	Buy	27,271,512 +1,957,999	+8%	+$368M	0.23%	77
2018 Q3	$4.31B	Buy	25,313,513 +47,617	+0.2%	+$8.1M	0.17%	108
2018 Q2	$4.14B	Buy	25,265,896 +411,507	+2%	+$67.5M	0.17%	105
2018 Q1	$4.02B	Buy	24,854,389 +763,407	+3%	+$123M	0.18%	105
2017 Q4	$3.52B	Buy	24,090,982 +368,439	+2%	+$53.8M	0.15%	121
2017 Q3	$3.22B	Buy	23,722,543 +926,649	+4%	+$126M	0.15%	126
2017 Q2	$2.85B	Buy	22,795,894 +563,460	+3%	+$70.6M	0.14%	131
2017 Q1	$2.64B	Buy	22,232,434 +806,282	+4%	+$95.8M	0.14%	136
2016 Q4	$2.47B	Buy	21,426,152 +618,829	+3%	+$71.4M	0.14%	138
2016 Q3	$2.17B	Buy	20,807,323 +675,566	+3%	+$70.6M	0.13%	156
2016 Q2	$1.96B	Buy	20,131,757 +406,686	+2%	+$39.6M	0.12%	165
2016 Q1	$1.89B	Buy	19,725,071 +699,344	+4%	+$67.2M	0.12%	159
2015 Q4	$1.72B	Buy	19,025,727 +561,735	+3%	+$50.9M	0.12%	168
2015 Q3	$1.71B	Buy	18,463,992 +776,416	+4%	+$72M	0.12%	159
2015 Q2	$1.65B	Buy	17,687,576 +62,443	+0.4%	+$5.81M	0.11%	181
2015 Q1	$1.67B	Buy	17,625,133 +867,778	+5%	+$82.2M	0.11%	183
2014 Q4	$1.49B	Buy	16,757,355 +605,216	+4%	+$53.7M	0.11%	193
2014 Q3	$1.29B	Buy	16,152,139 +360,642	+2%	+$28.8M	0.1%	212
2014 Q2	$1.12B	Buy	15,791,497 +359,393	+2%	+$25.5M	0.09%	235
2014 Q1	$1.14B	Buy	15,432,104 +357,082	+2%	+$26.4M	0.1%	220
2013 Q4	$1.18B	Buy	15,075,022 +256,538	+2%	+$20.1M	0.1%	193
2013 Q3	$1.09B	Buy	14,818,484 +458,163	+3%	+$33.8M	0.11%	185
2013 Q2	$1.09B	Buy	+14,360,321	New	+$1.09B	0.11%	163